| 1 |
33564107 | The use of intramuscular glucagon to prevent IV glucose infusion in early neonatal hypoglycemia. | 2021 May |
1 |
| 2 |
33105690 | The Neurotrophic Function of Glucagon-Like Peptide-1 Promotes Human Neuroblastoma Differentiation via the PI3K-AKT Axis. | 2020 Oct 22 |
3 |
| 3 |
30760847 | Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. | 2019 Apr |
1 |
| 4 |
31346639 | [Incretin-based co- and tri-agonists : Innovative polypharmacology for the treatment of obesity and diabetes]. | 2019 Sep |
2 |
| 5 |
26541888 | The effect of encapsulated glutamine on gut peptide secretion in human volunteers. | 2016 Mar |
2 |
| 6 |
26672638 | Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients. | 2016 May |
2 |
| 7 |
27038883 | Reappraisal of GIP Pharmacology for Metabolic Diseases. | 2016 May |
2 |
| 8 |
29147685 | Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment. | 2016 Sep |
2 |
| 9 |
25724479 | Brain GLP-1 and insulin sensitivity. | 2015 Dec 15 |
1 |
| 10 |
26042396 | Glucose-lowering medicines for type 2 diabetes. | 2015 May |
1 |
| 11 |
26598711 | The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling. | 2015 Nov 23 |
2 |
| 12 |
24144627 | Intravenous GLP-1 (7-36) amide for prevention of hyperglycemia during cardiac surgery: a randomized, double-blind, placebo-controlled study. | 2014 Jun |
3 |
| 13 |
24247476 | The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study. | 2014 Mar |
1 |
| 14 |
24641952 | Characterization of [¹²⁵I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta. | 2014 May 2 |
2 |
| 15 |
24804243 | Liraglutide suppresses obesity and hyperglycemia associated with increases in hepatic fibroblast growth factor 21 production in KKAy mice. | 2014 |
1 |
| 16 |
25317241 | Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors. | 2014 Oct 15 |
1 |
| 17 |
23181598 | Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans. | 2013 May |
2 |
| 18 |
23777457 | Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection. | 2013 Jun 18 |
1 |
| 19 |
24372261 | Developments of glucagon like peptide-1 (GLP-1) and long-acting analogs in clinical and preclinical studies for treatment of type 2 diabetes. | 2013 |
1 |
| 20 |
22202493 | Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients. | 2012 Jan |
1 |
| 21 |
22799463 | Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review. | 2012 Oct |
1 |
| 22 |
22938097 | Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection. | 2012 Oct 1 |
2 |
| 23 |
20152998 | Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus. | 2011 Jan |
2 |
| 24 |
21645806 | The GLP-1 mimetic exenatide potentiates insulin secretion in healthy cats. | 2011 Jul |
2 |
| 25 |
21647189 | GLP-1 and energy balance: an integrated model of short-term and long-term control. | 2011 Jun 7 |
1 |
| 26 |
24843499 | Glucagon-like peptide-1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52-week, randomized, multicenter trial. | 2011 Aug 2 |
1 |
| 27 |
24854977 | Management of unmet needs in type 2 diabetes mellitus: the role of incretin agents. | 2011 Dec |
1 |
| 28 |
20528633 | Contemporary management of patients with Type 2 diabetes. | 2010 Jun |
1 |
| 29 |
20646668 | Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation. | 2010 Jul |
1 |
| 30 |
21094907 | The role of GLP-1 in neuronal activity and neurodegeneration. | 2010 |
2 |
| 31 |
18786605 | The incretin system and its role in type 2 diabetes mellitus. | 2009 Jan 15 |
1 |
| 32 |
19037628 | Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. | 2009 Feb |
2 |
| 33 |
19878256 | Harnessing the weight-regulating properties of glucagon-like peptide-1 in the treatment of type 2 diabetes. | 2009 Dec |
3 |
| 34 |
18819251 | Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice. | 2008 |
1 |
| 35 |
17632702 | Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. | 2007 Sep |
1 |
| 36 |
17991647 | Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects. | 2007 Nov |
1 |
| 37 |
14759561 | Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1. | 2004 Apr 15 |
1 |
| 38 |
12673779 | GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells. | 2003 Mar-Apr |
2 |
| 39 |
11472275 | Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes. | 2001 Sep |
1 |
| 40 |
9661618 | Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia. | 1998 Jul |
2 |
| 41 |
8908380 | The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients. | 1996 Nov |
1 |
| 42 |
8993469 | On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects. | 1996 Dec 26 |
1 |